|
⚲
|
| Keyboard |
| Vhcp Management Eg LLC | |
|---|---|
| Firm | VR Adviser LLC |
| Address | 7 Bryant Park, 23rd Floor New York, NY 10018 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| VR Adviser LLC | |||||
| Venrock Healthcare Capital Partners EG LP | 021-365490 | Director | 446.8 M of 446.8 M |
2,404.0 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
KalVista Pharmaceuticals Inc KALV
Common Stock
|
2026-03-26 | Sell | 3,183 | $19.12 | 60,859 |
|
KalVista Pharmaceuticals Inc KALV
Common Stock
|
2026-03-26 | Sell | 21,386 | $17.76 | 379,815 |
|
KalVista Pharmaceuticals Inc KALV
Common Stock
|
2026-03-26 | Sell | 15,417 | $18.82 | 290,148 |
|
KalVista Pharmaceuticals Inc KALV
Common Stock
|
2026-03-25 | Sell | 174,485 | $16.95 | 2,957,521 |
|
KalVista Pharmaceuticals Inc KALV
Common Stock
|
2026-03-25 | Sell | 160 | $17.53 | 2,805 |
|
KalVista Pharmaceuticals Inc KALV
Common Stock
|
2025-04-09 | Buy | 25,000 | $9.42 | 235,500 |
|
Oruka Therapeutics Inc ORKA
Common Stock
|
2025-02-14 | Buy | 88,794 | $11.44 | 1,015,803 |
|
KalVista Pharmaceuticals Inc KALV
Common Stock
|
2025-02-13 | Buy | 61,700 | $9.33 | 575,661 |
|
Oruka Therapeutics Inc ORKA
Common Stock
|
2025-02-13 | Buy | 14,950 | $11.63 | 173,868 |
|
Oruka Therapeutics Inc ORKA
Common Stock
|
2025-02-12 | Buy | 8,971 | $11.86 | 106,396 |
|
KalVista Pharmaceuticals Inc KALV
Common Stock
|
2025-02-12 | Buy | 100,000 | $9.23 | 923,000 |
|
KalVista Pharmaceuticals Inc KALV
Common Stock
|
2025-02-11 | Buy | 26,703 | $9.18 | 245,134 |
|
Oruka Therapeutics Inc ORKA
Common Stock
|
2025-02-11 | Buy | 9,593 | $10.95 | 105,043 |
|
KalVista Pharmaceuticals Inc KALV
Common Stock
|
2025-02-10 | Buy | 4,137 | $9.14 | 37,812 |
|
Oruka Therapeutics Inc ORKA
Common Stock
|
2025-02-10 | Buy | 574 | $10.90 | 6,257 |
|
KalVista Pharmaceuticals Inc KALV
Common Stock
|
2025-02-07 | Buy | 73,649 | $9.29 | 684,199 |
|
KalVista Pharmaceuticals Inc KALV
Common Stock
|
2025-02-03 | Buy | 14,562 | $9.22 | 134,262 |
|
KalVista Pharmaceuticals Inc KALV
Common Stock
|
2025-01-31 | Buy | 11,754 | $8.89 | 104,493 |
|
KalVista Pharmaceuticals Inc KALV
Common Stock
|
2025-01-30 | Buy | 43,707 | $8.76 | 382,873 |
|
KalVista Pharmaceuticals Inc KALV
Pre-Funded Warrants (Right to Buy) · derivative
|
2024-02-20 | Buy | 655,738 | $15.25 | 10,000,004 |
| showing 20 of 93 most recent transactions | |||||